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Abstract
Background: Spain shows the highest bladder cancer incidence rates in men among European
countries. The most important risk factors are tobacco smoking and occupational exposure to a
range of different chemical substances, such as aromatic amines.
Methods: This paper describes the municipal distribution of bladder cancer mortality and attempts
to "adjust" this spatial pattern for the prevalence of smokers, using the autoregressive spatial model
proposed by Besag, York and Molliè, with relative risk of lung cancer mortality as a surrogate.
Results: It has been possible to compile and ascertain the posterior distribution of relative risk for
bladder cancer adjusted for lung cancer mortality, on the basis of a single Bayesian spatial model
covering all of Spain's 8077 towns. Maps were plotted depicting smoothed relative risk (RR)
estimates, and the distribution of the posterior probability of RR>1 by sex. Towns that registered
the highest relative risks for both sexes were mostly located in the Provinces of Cadiz, Seville,
Huelva, Barcelona and Almería. The highest-risk area in Barcelona Province corresponded to very
specific municipal areas in the Bages district, e.g., Suría, Sallent, Balsareny, Manresa and Cardona.
Conclusion: Mining/industrial pollution and the risk entailed in certain occupational exposures
could in part be dictating the pattern of municipal bladder cancer mortality in Spain. Population
exposure to arsenic is a matter that calls for attention. It would be of great interest if the
relationship between the chemical quality of drinking water and the frequency of bladder cancer
could be studied.
Background
In a European context, Spain ranks high in terms of blad-
der cancer mortality (2nd) in men, yet in women it figures
among the countries with the lowest rates. During 2002,
there were 3492 deaths in men and 703 in women due to
this tumour, with an age-adjusted mortality rate (Euro-
pean population) of 14.01 in men and 1.78 in women per
100,000 population. Bladder cancer accounted for 6%
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and 2% of cancer deaths in men in women, respectively.
In Spain, it is the 5th leading cause of cancer-related death
in men and the 13th in women, with a sex ratio of 4:1. It is
estimated that Spain has an average of 14,400 new cases
per annum. The most frequent histological type is transi-
tional cell (93%), followed by squamous cell cancer (2%)
and adenocarcinomas (1%). The high bladder cancer sur-
vival rate (75% at 5 years in men and 70% in women) [1]
means that partial prevalence (cases diagnosed in the last
5 years) is very high, viz., close on 40,000. This figure is
very similar to that for the most frequent tumours, such as
colorectal cancer, and thus constitutes an important pub-
lic health problem here in Spain.
Spatial analysis of health events (spatial epidemiology) is
a discipline that, though still in the development phase, is
already enjoying a space of its own in the field of health
research [2,3]. Its ability to suggest and detect the possible
sources of heterogeneity (generally of environmental ori-
gin) which determine the spatial patterns of incidence and
mortality due to different diseases, imbues this tool with
great interest in the sphere of epidemiology and public
health. Its potential is, moreover, being reinforced by the
ever increasing availability of geographically-indexed
population mortality and incidence data, together with
advances in computation techniques and Geographic
Information Systems. These circumstances are favouring
the analysis of the geographical distribution of health data
with growing levels of disaggregation [3], an area that
encompasses the so-called small-area studies.
The main advantages of such small-area studies are: a)
better interpretability of results in comparison with larger-
scale studies; b) less susceptibility to ecological biases;
and c) enhanced ability to detect local effects linked to
environmental problems, such as industrial pollution [4].
The most important risk factor in bladder cancer is
tobacco use, with the risk increasing in proportion to the
intensity of smoking habit [5]. This tumour is also associ-
ated with occupational exposure to a range of chemical
substances, such as 2-naphtilamine, benzidine and 4-ami-
nobiphenyl, used in, among others, textile mills (dyeing
and printing), the production of aromatic amines, and the
rubber and leather industries [6-8]. Other environmental
risk factors have also been described, such as exposure to
the chemical elements of drinking water, whether of nat-
ural origin or the result of industrial activities, e.g., arsenic
[9-13], or alternatively, exposure to compounds derived
from water treatment/disinfection (trihalomethanes)
[14]. The presence of inorganic arsenic in some foods [15-
19] and its relationship with bladder cancer and other
tumours is also under study [11,13], though low level
arsenic exposure is unlikely to explain a substantial excess
risk of bladder cancer [20].
It is assumed that the municipal spatial bladder cancer
distribution pattern is fundamentally dictated by the prev-
alence of smokers, at least in men. The approach used in
this study is based on the following idea: if it were possi-
ble "to extract" the smoking-habit component from
municipal maps (confounding effect), the resulting pat-
tern would then reflect the contribution of the remaining
risk factors.
This study sought: a) to display maps depicting the
municipal distribution of bladder cancer mortality; and
b) to obtain the spatial pattern "adjusted" for the preva-
lence of smokers. Accordingly, on the assumption that
lung cancer mortality is directly linked to the prevalence
of tobacco smokers, this variable was used as a surrogate
of tobacco use.
Methods
As case source, we used individual death entries for the
period 1989–1998 corresponding to bladder cancer (ICD-
9 code 188) and lung cancer (ICD-9 code 162), broken
down by town or city, nationwide. These data were fur-
nished by the National Statistics Institute (Instituto
Nacional de Estadística –  INE) for the production of a
municipal cancer mortality atlas, of which these results
form part.
Municipal populations, broken down by age group (18
groups) and sex, were obtained from the 1991 census and
1996 municipal roll. These years correspond to the mid-
points of the two quinquennia that comprise the study
period (1989–1993 and 1994–1998). The person-years
for each five-year period were obtained by multiplying
these populations by 5.
Standardised mortality ratios (SMR) were calculated as
the ratio of observed and expected deaths. For the calcula-
tion of expected cases, the overall Spanish mortality rates
for the above two 5-year periods were multiplied by each
town's person-years by age group, sex and quinquennium.
For map plotting purposes, smoothed municipal relative
risks (RR) were calculated using the conditional autore-
gressive model proposed by Besag, York and Molliè
(BYM). This model was introduced by Clayton and Kaldor
[21], developed by Besag, York and Molliè [22], and sub-
sequently applied in the field of ecological studies [23].
These models are based on fitting Poisson spatial models
with observed cases as the dependent variable, expected
cases as offset, and two types of random effects terms
which take the following into account: a) municipal con-
tiguity (spatial term); and b) municipal heterogeneity.
The models were fitted using Bayesian Markov chain
Monte Carlo simulation methods with non-informativeBMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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priors [24]. Posterior distributions of relative risk were
obtained using WinBugs [25]. The criterion of contiguity
used was adjacency of municipal boundaries. Conver-
gence of the simulations was verified using the BOA
(Bayesian Output Analysis) R program library [26]. Given
the great number of parameters of the models, the conver-
gence analysis was performed on a randomly selected
sample of 10 towns and cities, taking 4 strata defined by
municipal size. Convergence of the estimators was
achieved before 100,000 iterations. For the maps shown,
a "burn-in" (iterations discarded to ensure convergence)
of 300,000 iterations was performed and the posterior
distribution was derived with 5,000.
Thereafter a model was constructed for bladder cancer,
similar to the above model but adding, as another fixed-
effects term, the posterior distribution of RR for lung can-
cer normalised by means of its logarithm.
A Geographic Information System was used to plot
municipal maps that depicted smoothed RR estimates and
the distribution of the posterior probability (pp) that
RR>1 (Bayesian version of p value). With regard to this
indicator, we followed Richardson's criterion [4], which
recommends that probabilities above 0.8 should be
deemed significant.
Separate analyses were performed for men and women.
Results
From 1989 to 1998, a total of 34281 bladder cancer
deaths were registered in Spain, 28173 in men and 6108
in women. In 3824 towns and cities no death due to this
cause was registered. Using these data, an acceptable com-
putation time and conventional computers, it was possi-
ble to compile and ascertain the posterior distribution of
relative risk on the basis of a single spatial model that
included all of Spain's 8077 towns and cities and the
46398 adjacencies existing between them. Table 1 dis-
plays a number of descriptive statistics for the population
and disease data. The total population was just under 40
million, and lung cancer mortality was four times higher
than that of bladder cancer, with the mean number of
cases per area being 19 and 4 for lung and bladder cancer,
respectively.
Figure 1 depicts the distribution of the smoothed RR: a)
for bladder cancer; and b) for lung cancer (both sexes).
The patterns of both tumours display similarities as well
as differences: the similarities consist of the higher risk
found in many of the towns and cities in the Provinces of
Cadiz, Huelva and Seville, in Almería, and along the coast
of the Valencian Region; the most marked differences cor-
respond to Extremadura, Asturias, and Barcelona Prov-
ince.
Figures 2a and 2b show the distributions of bladder can-
cer in men and women. The patterns were different, with
less variability in women, yet in both sexes there were 3
large areas, namely, Western Andalusia, Almería and Cata-
lonia.
Shown in Figures 2c and 2d is the distribution of RR for
bladder cancer "adjusted" for distribution of the log(RR)
in lung cancer. This map highlights the differences
between the bladder and lung cancer maps. Figures 2e and
2f "filter" the previous figures, flagging the areas in which
excess mortality is more likely.
The towns and cities that registered a risk in excess of 1.30
(Figures 2a and 2b), totalled 101 in men and 36 in
women, and belonged, for the most part to the Provinces
of Cadiz, Seville, Huelva, Barcelona and Almería. Table 2
shows the results for towns and cities that, with at least 5
observed cases, registered adjusted RR of 1.3 or more and
pp ≥ 0.9 in men or women.
The highest risk area recorded by Barcelona Province cor-
responded to very specific municipal areas in the Bages
district, e.g., Suría, Sallent, Balsareny, Manresa and Car-
Table 1: Summaries of population and cancer mortality in the 8077 Spanish towns. Spain 1989–1998.
Total Mean Median Standard deviation Minimum Maximum No. (%) of areas with 
zero counts
Population 39648759 4908.85 586 42430.43 5 2866850 0 (0)
Observed bladder 34281 4.24 1 40.77 0 2543 3823 (47.3)
Expected bladder 34333 4.25 0.92 39.33 0.01 2721.16 0 (0)
Bladder SMRs1 - 0.76 0.39 1.19 0 26.32 3823 (47)
Observed lung 155014 19.19 3 190.03 0 12434 1905 (24.6)
Expected lung 155207 19.22 3.79 177.00 0.04 12243.54 0 (0)
Lung SMRs1 - 0.72 0.69 0.64 0 14.82 1905 (24.6)
1Descriptive values of the 8077 SMRsBMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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Municipal distribution of bladder and lung cancer mortality in Spain Figure 1
Municipal distribution of bladder and lung cancer mortality in Spain. Distribution pattern of smoothed relative risk (RR) under 
the BYM model. Spain 1989–1998.
Lung cancer (ICD-9 162)
Smoothed RR. 1989-1998
1.5  and more   (43)
1.3  - 1.5   (180)
1.1  - 1.3   (559)
1.05 - 1.1   (203)
0.95 - 1.05   (596)
0.91 - 0.95   (356)
0.77 - 0.91   (1566)
0.67 - 0.77   (1663)
0  - 0.67   (3026)
Bladder cancer (ICD-9 188)
Smoothed RR. 1989-1998
1.5  and more   (18)
1.3  - 1.5   (77)
1.1  - 1.3   (352)
1.05 - 1.1   (265)
0.95 - 1.05   (962)
0.91 - 0.95   (630)
0.77 - 0.91   (3705)
0.67 - 0.77   (1741)
0  - 0.67   (442)BMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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Municipal distribution of bladder cancer mortality: a) men, b) women, c) and d) men and woman respectively adjusted for lung  cancer mortality, e) and f) posterior probability of RR being greater than 1 Figure 2
Municipal distribution of bladder cancer mortality: a) men, b) women, c) and d) men and woman respectively adjusted for lung 
cancer mortality, e) and f) posterior probability of RR being greater than 1. Spain 1989–1998.
Bladder cancer. Men.
Smooted RR. 1989-1998
1.5  and more   (28)
1.3  - 1.5   (73)
1.1  - 1.3   (407)
1.05 - 1.1   (260)
0.95 - 1.05   (966)
0.91 - 0.95   (585)
0.77 - 0.91   (3258)
0.67 - 0.77   (1968)
0  - 0.67   (647)
Bladder cancer. Women
Smooted RR. 1989-1998
1.5  and more   (7)
1.3  - 1.5   (29)
1.1  - 1.3   (560)
1.05 - 1.1   (562)
0.95 - 1.05   (2145)
0.91 - 0.95   (2108)
0.77 - 0.91   (2534)
0.67 - 0.77   (125)
0  - 0.67   (122)
Bladder cancer. Men
RR adjusted by lung cancer
1.5  and more   (5)
1.3  - 1.5   (41)
1.1  - 1.3   (1255)
1.05 - 1.1   (1394)
0.95 - 1.05   (3114)
0.91 - 0.95   (984)
0.77 - 0.91   (1085)
0.67 - 0.77   (187)
0  - 0.67   (127)
Bladder cancer. Women
RR adjusted by lung cancer
1.5  and more   (1)
1.3  - 1.5   (10)
1.1  - 1.3   (1774)
1.05 - 1.1   (1088)
0.95 - 1.05   (3987)
0.91 - 0.95   (745)
0.77 - 0.91   (443)
0.67 - 0.77   (23)
0  a 0.67   (121)
Bladder  cancer (adjusted). Men
Posterior probability RR>1
0.9 - 1   (113)
0.8 - 0.9   (368)
0.2 - 0.8  (6548)
0.1 - 0.2   (590)
0  - 0.1   (573)
Bladder cancer (adjusted). Women
Posterior probability RR>1
0.9 - 1   (195)
0.8 - 0.9   (725)
0.2 - 0.8  (6814)
0.1 - 0.2   (257)
0  - 0.1   (201)BMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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Table 2: Bladder cancer mortality in Spain. Towns with 5 or more observed cases, which have shown an RR adjusted for lung cancer of 
over 1.3 in men or women, with a posterior probability (pp) of over 0.9 that RR is greater than 1 (p(RR>1)). Towns listed in order of 
province. Spain 1989–1998.
Town Both sexes Men Women
NAME INE Obs Exp SMR RR pp RR adj RR pp RR adj pp adj RR pp RR adj pp adj
EIVISSA 7026 31 17.87 1.74 1.49 0.99 1.38 1.64 1.00 1.50 1.00 0.81 0.30 0.79 0.23
SAN JOSE 7048 9 7.55 1.19 1.26 0.83 1.30 1.29 0.84 1.38 0.95 0.86 0.34 0.82 0.25
STA EULALIA DEL RIO 7054 16 13.18 1.21 1.23 0.85 1.33 1.26 0.87 1.39 0.96 0.86 0.33 0.81 0.25
BALSARENY 8018 9 3.82 2.35 1.41 0.96 1.38 1.48 0.96 1.38 0.98 1.13 0.76 1.23 0.89
CARDONA 8047 19 7.41 2.57 1.40 0.97 1.43 1.38 0.97 1.40 0.99 1.14 0.77 1.21 0.93
MANRESA 8113 93 70.84 1.31 1.24 0.99 1.24 1.11 0.82 1.12 0.88 1.42 0.99 1.34 0.99
MATARO 8121 109 77.07 1.41 1.32 1.00 1.17 1.25 0.98 1.08 0.77 1.36 0.98 1.32 0.97
SALLENT 8191 20 9.24 2.16 1.45 0.99 1.42 1.33 0.95 1.33 0.98 1.28 0.92 1.28 0.97
SURIA 8274 16 6.70 2.39 1.53 0.99 1.45 1.49 0.97 1.39 0.98 1.22 0.84 1.28 0.94
BURGOS 9059 168 134.86 1.25 1.17 0.98 1.33 1.21 0.99 1.37 1.00 0.93 0.25 1.01 0.49
ALGECIRAS 11004 109 62.39 1.75 1.71 1.00 1.25 1.89 1.00 1.33 1.00 1.00 0.51 0.99 0.45
CADIZ 11012 177 97.70 1.81 1.80 1.00 1.40 1.86 1.00 1.39 1.00 1.46 0.99 1.51 0.99
PUERTO DE STA MARIA 11027 70 33.62 2.08 1.90 1.00 1.43 2.08 1.00 1.49 1.00 1.08 0.67 1.12 0.77
PUERTO REAL 11028 30 15.08 1.99 1.73 1.00 1.37 1.79 1.00 1.37 0.99 1.17 0.82 1.19 0.88
ROTA 11030 27 12.55 2.15 1.83 1.00 1.38 1.97 1.00 1.45 1.00 1.08 0.64 1.12 0.71
SAN FERNANDO 11031 74 45.04 1.64 1.63 1.00 1.39 1.60 1.00 1.34 1.00 1.42 0.97 1.39 0.98
NARON 15054 38 25.05 1.52 1.35 0.98 1.32 1.35 0.97 1.31 0.98 1.07 0.60 1.00 0.45
CARIÑO 15901 16 6.29 2.55 1.75 0.99 1.43 1.80 0.99 1.43 0.98 1.09 0.58 1.03 0.52
LEPE 21044 14 9.72 1.44 1.38 0.95 1.06 1.29 0.89 0.99 0.44 1.30 0.81 1.33 0.91
SOLSONA 25207 14 7.48 1.87 1.34 0.89 1.44 1.26 0.82 1.37 0.95 1.22 0.76 1.28 0.87
PUERTO DEL ROSARIO 35017 12 6.75 1.78 1.22 0.75 1.28 1.37 0.86 1.51 0.94 0.36 0.03 0.24 0.02
BREÑA BAJA 38009 5 3.20 1.56 1.04 0.51 1.41 1.05 0.53 1.52 0.97 0.79 0.26 0.82 0.23
LLANOS DE ARIDANE 38024 21 13.83 1.52 1.15 0.75 1.53 1.23 0.84 1.68 1.00 0.75 0.22 0.80 0.20
VILLA DE MAZO 38053 6 5.80 1.04 0.99 0.44 1.41 1.01 0.48 1.53 0.98 0.78 0.26 0.83 0.23
TOCINA 41092 13 6.08 2.14 1.52 0.97 1.10 1.38 0.91 1.00 0.48 1.25 0.80 1.33 0.92
ELIANA 46116 14 5.42 2.59 1.46 0.97 1.26 1.62 0.98 1.32 0.96 0.88 0.21 0.96 0.36
INE = municipal code; Obs Exp = observed and expected deaths; RR = estimated relative risk; SMR = standard mortality ratio. RR adj = estimate 
adjusted for lung cancer. pp = posterior probability that RR>1.
dona. Other towns with relative risks in excess of 1.3 were
situated in Murcia, Burgos and Corunna (A Coruña).
Towns in Cadiz, Seville and Huelva registered a certain
excess risk for both sexes. In view of the peculiar spatial
pattern of these towns, it would seem that there are deter-
minants other than the high prevalence of smokers
accounting for the bladder cancer mortality pattern in this
area, since this same pattern is also applicable to women.
In Almería a sizeable area of raised risk was in evidence.
Barcelona Province was one of the areas that deserve some
comments. Two areas of higher risk were identified, one
comprising the Bages district (Suria, Sallent, Balsareny,
Manresa and Cardona), and the other flanking the coast
(Vilanova i la Geltru, Mataró), Barcelona, Barbera, Mon-
cada and Santa Coloma. In the Bages district, excess risk
was detected in both sexes: in the case of women, how-
ever, not only were the Bages towns identified, but the
areas marked on map were also larger. The posterior prob-
ability map identifies towns in Vallés, Maresme and Baix
Llobregat and an area in Tarragona around the Delta of
the River Ebro.
Discussion
The municipal geographical bladder cancer pattern is sim-
ilar to that plotted by lung cancer, possibly reflecting the
role of tobacco smoking, the leading etiological agent. The
difference in patterns with respect to lung cancer in terms
of both geographical distribution and time trend [27]
might be attributable to the existence of occupational
exposures and environmental differentials. In addition,
the differences with other countries in terms of mortality
frequency and trend [28] may possibly be related to black
tobacco (dark air cured tobacco) use among men, an
exposure which, for this tumour, has shown a higher risk
than that for other types of tobacco [6].
The origin of bladder cancer is determined by contact
between the vesical epithelium and carcinogenic sub-
stances excreted in urine. Such substances may be ingested
or inhaled directly, or come from the metabolism of otherBMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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products in the body. As mentioned above, the two risk
factors acknowledged as being most important for this
type of cancer are smoking and occupational exposure to
aromatic amines. Among the occupations associated with
a higher risk of bladder cancer are those linked to the pro-
duction of aromatic amines, rubber manufacture, expo-
sure to dyes and printing in the textile industry [7], paint,
aluminium, tanning and curing of hides, and the driving
of motor vehicles [6,8].
The risk associated with the consumption of chlorinated
drinking water was evaluated in different occasions. A
recent published metaanalysis indicates that long term
consumption of chlorinated drinking water is associated
with a 40% of increased risk of bladder cancer incidence,
particularly in men [14,29]. Those studies found an
increased risk of bladder cancer and a dose-response pat-
tern among men exposed to trihalomethanes at levels cur-
rently observed in many industrialized countries.
However they did not find an increased risk in women
and this observed difference in risk by sex is puzzling.
The municipal mortality pattern shown in Spain needs to
include another elements among possible explanations.
In the recent years, the role of other environmental expo-
sures, for instance arsenic, in the aetiology of bladder can-
cer (and other tumours), has gradually become
recognised. Inorganic arsenic has been documented as
being a skin and lung carcinogen [30,31]. A number of
studies have observed a rise in bladder and kidney cancer
mortality in populations with high exposure to arsenic in
drinking water [9,10,32,33] and, in the case of bladder
cancer, a dose-response relationship has been reported
[11,12].
The method applied to smooth geographical patterns,
with the limitations commented below, is currently the
most widely accepted method for data studies focusing on
small areas [2,3]. One aspect that merits comment is the
use of lung cancer mortality as a surrogate variable to
adjust for exposure to tobacco. A single aetiological agent,
cigarette smoking, is by far the leading cause of lung can-
cer, accounting for approximately 90% of lung cancer
cases in countries where cigarette smoking is common
[34]. Nowadays, the risk of lung cancer posed to smokers
is about 20 times greater than that posed to never-smokers
[34]. Few exposures to environmental agents convey such
risks for any disease. The unequivocal causal association
between cigarette smoking and lung cancer is one of the
most thoroughly documented causal relationships in bio-
medical research [34]. Hence, to consider the distribution
of lung cancer as a good indicator of the prevalence of
smokers is by no means illogical, although this ecological
approach is subject to residual confounding.
The joint modelling of several diseases is something that
has been addressed on different occasions with varying
approaches [35-37]. Recently, two papers have been pub-
lished on spatial variation in the rates of several diseases
with common risk factors, an approach known as "joint
disease mapping' [38,39]. Our method of analysis is
described as an 'ecological regression' in the paper by
Held et al., and in their paper, Dabney et al. provide exam-
ples of modelling procedures with lung and bladder can-
cer incidence.
In our results, the effect of adjusting for lung cancer is to
produce a "filtering" of the geographical pattern, extract-
ing from the maps those towns and cities in which blad-
der cancer mortality can be explained by tobacco use
(Figure 2c and 2d).
Most of the municipal areas identified by the models as
representing a raised risk for both sexes are situated in the
Provinces of Cadiz, Seville and Huelva. On the map
adjusted for lung cancer, the towns that are highlighted
are listed in order of their proximity to the River Guad-
alquivir. This, coupled with the fact that this pattern is
also seen among women, is indicative that there are envi-
ronmental components other than the prevalence of
smokers underlying bladder cancer mortality in this area.
The environs of the Huelva estuary and the Campo de
Gibraltar district have been the subject of study and spe-
cific reports by the Scientific Research Board (Consejo
Superior de Investigaciones Científicas – CSIC) on the serious
situation of their environmental pollution, with high con-
centrations of heavy metals being detected in sediments
throughout the area [40].
The content of these reports [40] and the municipal mor-
tality patterns suggest that industrial activity in the Prov-
ince of Cadiz, and industrial and mining activity in the
Provinces of Seville and Huelva could be associated with
bladder cancer mortality in these provinces. Furthermore,
bearing in mind the levels of arsenic and other heavy met-
als in fish and shellfish [15,41,42], questions might well
be raised about the possible role played in the incidence
of this tumour by the high consumption of fish in Spain
[43] and regional differences in such consumption. The
maximum limits of arsenic in foodstuffs are still not regu-
lated [40]. In comparison with other European countries,
however, Spain has high rates in men only, with bladder
cancer in women being extremely infrequent. On the
other hand, however, risk of bladder cancer for exposure
to low doses of arsenic is reported to have been observed
only in smokers [44,45].
In the smoothed maps for Barcelona Province, two areas
with higher than expected mortality were detected, one in
the Bages district and the other in Vallés, Maresme andBMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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Baix Llobregat. These two areas differ, in that whereas in
the former the risk is higher in both sexes, in the latter this
is true only of women (Figures 2a and 2b).
Wholly different explanations might account for these
patterns. The Bages pattern affects men and women,
which could be interpreted as due to some environmental
exposure other than occupation. The Bages district has
been characterised by sodium and potash mining and the
textile industry. The mining industry faithfully reflects the
towns of Cardona (salt mines worked from 1923 to 1990
by ERCROS), Suria, Sallent, Balsareny (sodium chloride
and potash mines, run by Iberpotash). Mining-specifically
salt mining [8] – is one of the occupations in which an
association has been described with bladder cancer. High
concentrations of arsenic have been detected in the
Cardener and Llobregat Rivers, concentrations that have
clearly increased due to the influence of the mining activ-
ity in Sallent-Balsareny [46]. Moreover, in the 1930s the
Bages district and Llobregat basin were the leading cotton-
based textile industry areas in Catalonia [47].
The Vallés/Maresme pattern, which is only observable in
women, might be related to the textile industry tradition-
ally situated in these areas. Textiles, particularly cotton,
constituted the strongest sector by far in Catalonian
industrialisation, a sector characterised by an abundant
presence of women workers. Dyeing and printing are the
sections that have shown an association with bladder can-
cer in the literature [7]. Posterior studies conducted in Bar-
celona province do not support the findings respective to
the textile industry although they found very high relative
risks in workers employed for very long [48]. In a pooled
analysis of occupation and bladder cancer in women, the
increased risk in textile industry is for exposed for more
than 25 years [49]. In a more recent update the opinion is
that there is a general tendency to move toward unity for
all the cancer relative risk estimates in textile industry
workers [50]. Some exposures to carcinogens could be
limited in time, with the improving of industrial proce-
dures.
Some authors have described an association between
arsenic levels in drinking water and the incidence of cer-
tain tumours, including transitional cell carcinomas of the
urinary bladder [51]. It could be argued that maximum
levels of arsenic in drinking water are limited by law and
are routinely monitored, so that any substantial excess
risk would be difficult to explain. Nevertheless, the limit
on arsenic levels in water is currently under discussion.
Until 1990 the maximum permissible level in Spain of
arsenic intended for human consumption was 100 µg/l.
This was then reduced to 50 µg/l. Subsequently, the Euro-
pean Council Directive 98/83/EC of 3 November 1998 on
the quality of water intended for human consumption,
applied the World Health Organisation (WHO) guideline
and set the maximum admissible concentration for this
element at 10 µg/l, the level adopted in Spain at the end
of 2003 (Royal Decree 140/2003). These data not only
attest to the controversy surrounding the health risk of
ingesting inorganic arsenic and the advisability of present
and future limits [52,53], but also mean that for many
years the permitted levels of arsenic in drinking water
have been up to 10 times higher than those now tolerated.
The hypothesis of exposure to arsenic would be rein-
forced, if the proportion of the population that drinks
well-water and is thus more difficult to control, were
higher in areas with higher risks of bladder cancer, but this
is something that we do not know.
The use of arsenic-based pesticides has been viewed as the
principal source of arsenic-related environmental pollu-
tion in recent decades [17]. Phytosanitary products are
used intensively in areas like Almería, a factor that calls for
detailed study.
Arsenic can also been found in certain pesticides and in
wood preservatives. In the past, arsenic was primarily used
as a pesticide, primarily on cotton fields and in orchards.
Inorganic arsenic compounds can no longer be used in
agriculture. However, organic arsenicals, namely
cacodylic acid, disodium methylarsenate (DSMA), and
monosodium methylarsenate (MSMA) are still used as
pesticides, principally on cotton [54].
Andalusia holds almost 95% of cotton cultivated surface,
which represents 2% of its cropland. Cotton crops are
mainly found in Occidental Andalusia (Seville, Cadiz,
Cordoba), in the region known as " Bajo Guadalquivir",
and to a much lesser extent, in Huelva. In "Bajo Guad-
alquivir" other usual crops are sunflower, beetroot and
cereals such as rice, in which pesticide use has also been
quite common.
Another possible source of arsenic might be occupational
exposure to chromated copper arsenate (CCA), which is
an inorganic arsenic compound commonly used as wood
preservative for outdoor furnitures [55,56]. The marketing
and use of this substance (CCA) as wood preservant and
the commercialization of the products treated with it has
been recently banned (COMMISSION DIRECTIVE 2003/
2/ES january 6, 2003).
Geographical small-area studies such as ours, though tar-
geted at generating aetiological hypotheses, can be effi-
cient instruments for detecting problems connected with
environmental quality and, in addition, furnish very flex-
ible information which enables some of the limitations
posed by classic ecological studies to be overcome. The
results suggest that mining/industrial pollution and theBMC Public Health 2006, 6:17 http://www.biomedcentral.com/1471-2458/6/17
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risk entailed in certain occupational exposures could in
part be dictating the pattern of municipal bladder cancer
mortality in Spain. Population exposure to arsenic found
in diet and drinking water is a matter that calls for atten-
tion. Accordingly, it would seem advisable to study the
possible restriction of inorganic arsenic levels in foods
and to explore whether some relationship exists between
the chemical quality of drinking water and the frequency
of bladder cancer in Spain. Also the use of arsenical pesti-
cides deserve attention in Occidental Andalucía and Alm-
ería.
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